Table 3.
Logistic regression analysis to predict GLS abnormality (GLS ≤18).
| Overall | non-CAD | CAD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables | Crude OR (95%CI) | P | Adjusted OR (95%CI)* | P | Crude OR (95%CI) | P | Adjusted OR (95%CI)* | P | Crude OR (95%CI) | P | Adjusted OR (95%CI)* | P |
| Age (per year) | 1.04 (1.01–1.08) | 0.010 | 1.03 (1.00–1.07) | 0.094 | 1.05 (0.98–1.13) | 0.172 | 1.02 (0.95–1.11) | 0.555 | 1.03 (0.99–1.07) | 0.200 | 1.04 (0.99–1.08) | 0.106 |
| Male sex (yes or no) | 0.64 (0.33–1.23) | 0.176 | 0.53 (0.22–1.29) | 0.534 | 0.82 (0.19–3.58) | 0.790 | 0.32 (0.05–2.17) | 0.241 | 0.71 (0.32–1.54) | 0.380 | 0.58 (0.20–1.62) | 0.295 |
| Body mass index (kg/m2) | 1.00 (0.94–1.07) | 0.906 | 1.03 (0.94–1.12) | 0.544 | 0.93 (0.79–1.11) | 0.440 | 0.86 (0.66–1.11) | 0.243 | 1.03 (0.96–1.12) | 0.407 | 1.06 (0.96–1.17) | 0.241 |
| Smoking history (yes or no) | 1.02 (0.53–1.98) | 0.945 | 1.82 (0.75–4.42) | 0.186 | 3.77 (0.43–32.7) | 0.229 | 6.44 (0.58–71.6) | 0.130 | 1.03 (0.48–2.22) | 0.933 | 1.35 (0.48–3.76) | 0.567 |
| Dyslipidemia (yes or no) | 0.60 (0.26–1.36) | 0.217 | 0.60 (0.22–1.60) | 0.306 | 1.30 (0.28–5.99) | 0.741 | 0.82 (0.14–4.81) | 0.825 | 0.60 (0.21–1.70) | 0.334 | 0.44 (0.13–1.53) | 0.198 |
| Hypertension (yes or no) | 0.97 (0.43–2.20) | 0.945 | 1.22 (0.47–3.16) | 0.689 | 1.21 (0.22–6.69) | 0.831 | 0.88 (0.11–6.84) | 0.906 | 0.67 (0.27–1.63) | 0.374 | 1.27 (0.42–3.85) | 0.676 |
| Type 2 diabetes mellitus (yes or no) | 2.17 (1.02–4.62) | 0.045 | 2.33 (1.01–5.38) | 0.047 | 1.50 (0.28–8.11) | 0.638 | 2.29 (0.28–18.9) | 0.442 | 2.54 (1.05–6.12) | 0.038 | 2.69 (1.04–6.94) | 0.041 |
| Coronary artery disease (yes or no) | 5.04 (2.20–11.5) | <0.001 | 3.99 (1.65–9.79) | 0.002 | – | – | – | – | – | – | – | - |
| EATV ≥116 ml (yes or no) | 2.54 (1.31–4.92) | 0.006 | 2.22 (1.03–4.79) | 0.042 | 3.33 (0.72–15.4) | 0.123 | 6.29 (0.89–44.7) | 0.066 | 2.03 (0.94–4.39) | 0.072 | 1.61 (0.67–3.87) | 0.285 |
OR, odds ratio.
*
OR adjusted for age, male sex, body mass index, smoking history, dyslipidemia, Hypertension, type 2 diabetes mellitus, coronary artery disease and EATV ≥116 ml. CAD, coronary artery disease; EATV, epicardial adipose tissue volume.